[Severe hypertension with cardiac failure and nephrosclerosis after oral contraceptives (author's transl)].
D000328:Adult; D000959:Antihypertensive Agents / Q000627:therapeutic use; D006328:Cardiac Catheterization; D003276:Contraceptives, Oral / Q000009:adverse effects*; D004077:Digoxin / Q000627:therapeutic use; D004417:Dyspnea / Q000139:chemically induced; D004562:Electrocardiography; D004997:Ethinyl Estradiol / Q000009:adverse effects*; D005260:Female; D006333:Heart Failure / Q000139:chemically induced*; D006801:Humans; D006973:Hypertension / Q000139:chemically induced* / Q000150:complications / Q000188:drug therapy; D007444:Inulin; D007677:Kidney Function Tests; D008099:Liver / Q000378:metabolism; D008234:Lynestrenol / Q000009:adverse effects*; D009400:Nephrosclerosis / Q000139:chemically induced*; D012083:Renin / Q000378:metabolism; D012110:Reserpine / Q000627:therapeutic use; D013894:Thirst / Q000187:drug effects
D000959:Antihypertensive Agents; D003276:Contraceptives, Oral; D004997:Ethinyl Estradiol; D004077:Digoxin; D012110:Reserpine; D007444:Inulin; D012083:Renin; D008234:Lynestrenol
Schwere Hypertonie mit Herzinsuffizienz und Nephrosklerose nach Einnahmeoraler Antikonzeptiva.